关键词: 子宫内膜异位症, 复发, 长期管理

Abstract: Endometriosis is a chronic recurrent and systemic disease with an annual recurrence rate of about 10%. Recurrent ovarian endometriosis generally refers to the recurrence of ovarian endometrioma， which is the most common recurrence type of endometriosis and the main reason for reoperation. The treatment principle basically follows the initial treatment， but should be individualized. Treatment includes both medical and surgical treatment. The drugs commonly used include progestins， gonadotropin releasing hormone agonist（GnRH-a）， compound oral contraceptives and traditional Chinese medicine. Some drugs， such as dienogest， can significantly reduce the size recurrent ovarian endometrioma or even make it disappear， thus avoiding the risk of reoperation，which has been widely recommended in recent years.Reoperation has a greater negative impact on ovarian reserve function，and it is still very likely to have relapse after reoperation. Some patients can also choose ultrasound-guided puncture therapy. IVF is first recommended for patients with infertility. Drug maintenance therapy and long-term management are the key to reducing the recurrence of ovarian endometrioma. It has been proved that long-term use of progestins，GnRH-a and compound oral contraceptives can prevent the recurrence of ovarian endometrioma.

Key words: endometriosis, recurrence, long-term management